-
Medical journals
- Career
Diabetes and obesity - Issue 47/2024
Editorial
Reviews
13Integration of glycemic compensation markers, including glycemic variability in patients with diabetes mellitusOliver Viktor Rácz, Eva Lovásová, Jaroslava Nováková, Adriana Phillipiová
25Inklisiran and its role in lipid-lowering therapyOlga Bobelová
33Slovak Diabetes Society recommendations for diabetes educationMarek Macko Vedúci Autorského Kolektívu, Andrea Bukovská, Peter Galajda, Marián Mokáň, Zbynek Schroner, Za Výbor Slovenskej Diabetologickej Spoločnosti
36Type 2 diabetes mellitus and obesity – dangerous companionsZbynek Schroner
415362Long-term sustainability of metabolic compensation in telemedicine use – results of 18 months follow-upJozef Lacka, Pavol Košík, Klaudia Mesíková
70Diabetic distress from clinical diabetology viewDaniel Kolény, Marcela Murínová
News
7880Pilot project for early detection of hyperglycemia, prediabetes and/or diabetes mellitus in insured persons of VšZP, a.s., and throughout Slovakia in specialist outpatient clinics of diabetologists in diabetes-naïve patients: reportKatarína Černá, Viera Doničová, Adriana Ilavská, Zbynek Schroner
82
Personalities
News
88Diabetics from all over Slovakia on reconditioning staysJozef Borovka
Diabetes and obesity
2024 Issue 47
Most read in this issue- Slovak Diabetes Society recommendations for diabetes education
- Type 2 diabetes mellitus and obesity – dangerous companions
- Current position of GLP-1 receptor agonists in type 2 diabetes mellitus treatment
- Coexistence of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of a patient with type 2 diabetes mellitus
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career